Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
HCC1954
Description:
HCC1954 is a human breast cancer cell line used in laboratory research on cancer biology and treatment response.
Primary topic:
HER2/EGFR in Cancer Research (35%)
Related topics:
HER2/EGFR in Cancer Research (35%),
PI3K/AKT/mTOR signaling in cancer (8%)
OpenAlex ID:
keywords/hcc1954
β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib
2011
·
Catherine Huang
, Catherine C Park
, et al.
·
Breast Cancer Research
·
187
PDF
Analysis of estrogen receptor isoforms and variants in breast cancer cell lines
2011
·
MAIE AL-BADER
, CHRISTOPHER FORD
, et al.
·
Experimental and Therapeutic Medicine
·
112
PDF
Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session
2020
·
Marion M. Deken
, Marta M. Kijanka
, et al.
·
Journal of Controlled Release
·
88
PDF
Controlled Extracellular Matrix Degradation in Breast Cancer Tumors Improves Therapy by Trastuzumab
2010
·
Ines Beyer
, Zongyi Li
, et al.
·
Molecular Therapy
·
73
Separation of a Breast Cancer Cell Line from Human Blood Using a Quadrupole Magnetic Flow Sorter
2001
·
M. Nakamura
, K. Decker
, et al.
·
Biotechnology Progress
·
61
Nanopore sequencing of DNA concatemers reveals higher-order features of chromatin structure
2019
·
Netha Ulahannan
, Matthew Pendleton
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
60
PDF
Reassessment of estrogen receptor expression in human breast cancer cell lines.
2011
·
Christopher H J Ford
, Maie Al-Bader
, et al.
·
PubMed
·
57
mRNA Profiling Reveals Determinants of Trastuzumab Efficiency in HER2-Positive Breast Cancer
2015
·
Silvia von der Heyde
, Steve Wagner
, et al.
·
PLoS ONE
·
52
PDF
A combination treatment with DNA methyltransferase inhibitors and suramin decreases invasiveness of breast cancer cells
2014
·
Sahra Borges
, Heike R. Döppler
, et al.
·
Breast Cancer Research and Treatment
·
48
The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice
2000
·
Birgitta Clinchy
, Adi Gazdar
, et al.
·
Breast Cancer Research and Treatment
·
41
Heterotypic Tumor Spheroids in Agitation-Based Cultures: A Scaffold-Free Cell Model That Sustains Long-Term Survival of Endothelial Cells
2021
·
Teresa Franchi-Mendes
, Nuno Lopes
, et al.
·
Frontiers in Bioengineering and Biotechnology
·
40
PDF
Targeting triple-negative breast cancer cells with 6,7-bis(hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles
2014
·
Kathleen Santos
, Mafalda Laranjo
, et al.
·
European Journal of Medicinal Chemistry
·
40
CD147 knockdown improves the antitumor efficacy of trastuzumab in HER2-positive breast cancer cells
2016
·
Lijuan Xiong
, Li Ding
, et al.
·
Oncotarget
·
27
Adhesion, proliferation, and apoptosis in different molecular portraits of breast cancer treated with silver nanoparticles and its pathway-network analysis
2018
·
Christian Rodríguez-Razón
, Irinea Yañez-Sánchez
, et al.
·
International Journal of Nanomedicine
·
26
PDF
Label-free LC-MS analysis of HER2+ breast cancer cell line response to HER2 inhibitor treatment
2015
·
Alessio Di Luca
, Michael Henry
, et al.
·
DARU Journal of Pharmaceutical Sciences
·
26
PDF
The Efficiency of Gene Electrotransfer in Breast-Cancer Cell Lines Cultured on a Novel Collagen-Free 3D Scaffold
2020
·
Elisabetta Sieni
, Monica Dettin
, et al.
·
Cancers
·
25
PDF
mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer
2022
·
David Casadevall
, Anna Hernández-Prat
, et al.
·
Molecular Cancer Research
·
24
PDF
DHA Affects Microtubule Dynamics Through Reduction of Phospho-TCTP Levels and Enhances the Antiproliferative Effect of T-DM1 in Trastuzumab-Resistant HER2-Positive Breast Cancer Cell Lines
2020
·
Silvia D’Amico
, Ewa Krasnowska
, et al.
·
Cells
·
23
Liquid-phase electron microscopy of molecular drug response in breast cancer cells reveals irresponsive cell subpopulations related to lack of HER2 homodimers
2017
·
Diana B. Peckys
, Ulrike Korf
, et al.
·
Molecular Biology of the Cell
·
23
PDF
Evaluation of AAV-mediated delivery of shRNA to target basal-like breast cancer genetic vulnerabilities
2019
·
Catarina Pinto
, Gabriela Silva
, et al.
·
Journal of Biotechnology
·
22
The effect of the alpha-specific PI3K inhibitor alpelisib combined with anti-HER2 therapy in HER2+/PIK3CA mutant breast cancer
2023
·
Maria Letizia Cataldo
, Pietro De Placido
, et al.
·
Frontiers in Oncology
·
21
PDF
Long-range massively parallel mate pair sequencing detects distinct mutations and similar patterns of structural mutability in two breast cancer cell lines
2011
·
Oliver A. Hampton
, Christopher A. Miller
, et al.
·
Cancer Genetics
·
19
Abstract 3934: Determination of the PI3Kα selective inhibitor alpelisib mechanism of action and efficacy in ER+/ PIK3CA mutant breast cancer preclinical models
2018
·
Christine Fritsch
, Estelle Pfister
, et al.
·
Cancer Research
·
18
Evaluation genotypes of cancer cell lines HCC1954 and SiHa by short tandem repeat (STR) analysis and DNA sequencing
2018
·
Jiewen Fu
, Jingliang Cheng
, et al.
·
Molecular Biology Reports
·
17
Complete Remissions of HER2-Positive Trastuzumab-Resistant Xenografts Using a Potent [225Ac]Ac-Labeled Anti-HER2 Antibody–Drug Radioconjugate
2024
·
Jessica Pougoue Ketchemen
, Fabrice Ngoh Njotu
, et al.
·
Clinical Cancer Research
·
15
Show more works
View as search
Works count:
146
Citation count:
1,264
Year
Topic
Type